In hepatocellular carcinoma, two studies consistently demonstrated that significantly increased PSG9 protein in the plasma exerted an important regulatory impact on tumor proliferation and progression and served as a self-contained biomarker for predicting prognosis (Rong et al., 2017; Rong et al., 2019). This evidence concerns the gene PSG9 and neoplasm.